Lung Cancer Screening
Tóm tắt
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths in the US. It as been shown that when treated in its early stages, survival rates improve. Despite this, controversy remains regarding screening for the early detection of lung cancer, primarily because mortality reductions were not observed in the trials that studied chest x-ray and sputum cytology. Nevertheless, renewed interest in screening, due in part to better screening options, has prompted further research exploring the potential cost-effectiveness of implementing lung cancer screening programs. This article provides a critical review of the literature of economic evaluations of lung cancer screening programs. The focus of this review is the methodology implemented in these studies. Based on an electronic search of the literature (Pubmed, Medline and CancerLit) from Sep 1988–Sep 2001, seven articles that quantified the cost-effectiveness of lung cancer screening programs were identified. For most of the studies, the cost-effectiveness aspect was a minor component with little or no description of the methods. Although some studies focused more on estimating the economic efficiency of screening, their methodology was weak and still not well documented. Only two studies implemented fully a cost-effectiveness analysis and provided the necessary level of detail. If consensus can be reached regarding the clinical benefit of lung cancer screening, future studies related to cost-effectiveness would have to be implemented on much sounder methodology. The publications reviewed do provide preliminary support for the economic efficiency of screening for lung cancer.
Tài liệu tham khảo
Healthy People 2010. Chapter 3: cancer [online]. Available from URL: www.health.gov/heathlypeople/document/html/volume1/03cancer.htm [Accessed 2002 Jan 15]
American Cancer Society. Cancer facts and figures 2001. Atlanta (GA): American Cancer Society, 2001
Guide to clinical preventive services. Chapter 11: screening for lung cancer [online]. Available from URL: http://text.nlm.nih.gov/cps/www/cps.17.html [Accessed 2002 Jan 15]
Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002; 52(1): 8–22
Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa: Canada Communication Group, 1994: 780–7
Henschke CI, Yankelevitz DF. CT screening for lung cancer. Lung Cancer 2000; 38(3): 487–95
Petty TL. Screening strategies for early detection of lung cancer: the time is now. JAMA 2000; 284(15): 1977–80
Strauss GM, Dominioni L. Perception, paradox, paradigm: Alice in Wonderland of lung cancer prevention and early detection. Cancer 2000; 89Suppl. 11: 2422S–31S
Miettinen OS. Screening for lung cancer. Lung Cancer 2000; 32: 479–86
Miettinen OS. Screening for lung cancer: can it be cost-effective? CMAJ 2000; 162(10): 1431–6
Deslauriers J. Should screening for lung cancer be revisited? J Thorac Cardiovasc Surg 2001; 121: 1031–2
Melamed MR, Flehinger BJ, Zaman ND, et al. Screening for early lung cancer: results of the Memorial Sloan-Kettering Study in New York. Chest 1984; 86(1): 44–53
Pontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med 1986; 28(8): 746–50
Kubík A, Polák J. Lung cancer detection: results of a randomized prospective study in Czechoslovakia. Cancer 1986; 57: 2427–37
Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99–105
Smith IE. Screening for lung cancer: time to think positive [commentary]. Lancet 1999; 354: 86–7
Annual Report on Health and Welfare 1999. Cancer Control [online]. Available from URL: http://www.mhlw.go.jp/english/wp/wp-hw/vol2/p2c3.html. [Accessed 2002 Apr 20]
Tsukada H, Kurita Y, Yokoyama A, et al. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study. Br J Cancer 2001; 85(9): 1326–31
Nishii K, Ueoka H, Kiura K, et al. A case-control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer 2001; 34: 325–32
Eddy DM. Screening for lung cancer. Ann Intern Med 1989; 111: 232–7
Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798–802
Okamoto N. Cost-effectiveness of lung cancer screening in Japan. Cancer 2000; 89Suppl. 11:2489S–93S
Baba Y, Takahshi M, Tominguchi S, et al. Cost-effectiveness decision analysis of mass screening for lung cancer. Acad Radiol 1998; 5Suppl. 2: 344S–6S
Caro JJ, Klittich WS, Strauss G. Could chest x-ray screening for lung cancer be cost-effective? Cancer 2000; 89Suppl. 11: 2502S–5S
Marshall D, Simpson KN, Earle CC, et al. Potential cost-effectiveness of one-time screening for lung caner (LC) in a high risk cohort. Lung Cancer 2001; 32: 227–36
Marshall D, Simpson KN, Earle CC, et al. Economic decision analysis model of screening for lung cancer. Eur J Cancer 2001; 37: 1759–67
Ebeling K, Nischan P. Screening for lung cancer: results from a case-control study. Int J Cancer 1986; 40: 141–4
Iinuma T, Tateno Y. A simple mathematical model for quantitative evaluation of mass screening for detection of cancer. Jpn J Cancer Clin 1990; 36: 2427–33
Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization: tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146(4): 473–81
Gold MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996